Akita, Japan

Mari Iwabuchi

This inventor holds 2 USPTO granted patents. Top assignees: Mitsubishi Chemical Corporation, Mitsubishi Corporation. Active years: 1999.


% Patents Active = 100.0

Average Co-Inventor Count = 4.4

ph-index = 2

Forward Citations = 53(Granted Patents)


Location History:

  • Akita, JP (1999)
  • Yamato, JP (1999)

Company Filing History:


Years Active: 1999

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Mari Iwabuchi: Innovator in Plant Biotechnology

Introduction

Mari Iwabuchi is a notable inventor based in Akita, Japan. She has made significant contributions to the field of plant biotechnology, particularly in enhancing the storage lipid content in plant seeds. With a total of 2 patents, her work has implications for agricultural productivity and crop improvement.

Latest Patents

One of her latest patents is a method for increasing storage lipid content in plant seeds. This innovative approach involves substantially lowering the activity of cytosolic pyruvate kinase in the seed compared to its endogenous activity. Additionally, the activity of phosphoenolpyruvate carboxylase is also reduced, leading to an increase in the storage lipid content of the plant seed. Another patent she holds is related to a gene that determines cytoplasmic sterility and a method of producing it.

Career Highlights

Throughout her career, Mari Iwabuchi has worked with prominent companies such as Mitsubishi Corporation and Mitsubishi Chemical Corporation. Her experience in these organizations has allowed her to develop and refine her innovative ideas in plant biotechnology.

Collaborations

Some of her notable coworkers include Jun Imamura and Takako Sakai, who have contributed to her research endeavors.

Conclusion

Mari Iwabuchi's work in plant biotechnology showcases her innovative spirit and dedication to improving agricultural practices. Her patents reflect her commitment to advancing the field and addressing challenges in crop production.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…